When a new treatment method is introduced to the medical community, everyone takes a step back and watches patiently. Everyone – doctors and patients – wants to know how safe the method is going to be for the community. With NeuroStar TMS Therapy, safety is paramount. In fact, through clinical trials, safety regulations have been met with wonderful results. Patients who have experienced less-than-ideal results from antidepressant medications are in good hands!
During clinical trials, NeuroStar TMS Therapy has led to few side effects, and many patients tolerated the treatment method well. The single most common side effect experienced by patients was scalp discomfort – a mild to moderate condition occurring less frequently after the first week of trials. Tweaks were also made to the system to prevent such discomfort.
Furthermore, less than 5% of all trial patients experienced adverse conditions and were forced to discontinue treatment. This is a profound number, considering over 10,000 active treatments were performed during the trial period.
NeuroStar Safety Facts
We’ve examined the numbers from clinical trials. Here are a few facts:
- There were no systemic side effects, including weight gain, sexual dysfunction, sedation, nausea, or dry mouth.
- Patients experienced no adverse effects on their memory or concentration abilities.
- There were no negative drug interactions.
Now, on to some warnings that ensure safety during TMS Therapy:
- NeuroStar TMS Therapy should never be used on a patient with implanted metallic devices or non-removable metallic objects in the head. Metallic fillings in teeth are fine, however.
- NeuroStar TMS Therapy should never be used on patients who have implants controlled via physiological signals, including pacemakers, cardioverter defibrillators (ICDs), and vagus nerve stimulators (VNS).